Company intelligence / Profile preview

Aimin Pharmaceutical

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Tianjin Aimin Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the development and manufacture of treatments for obesity and metabolic disorders. Founded in 1992 and headquartered in Tianjin, the company is closely associated with the Aimin Fat Reduction Hospital and its acupuncture-based weight loss methodologies. Its product portfolio includes both traditional Chinese medicines and modern pharmaceutical formulations targeting hyperlipidemia and weight management. Aimin Pharmaceutical operates large-scale manufacturing facilities and distributes its products both domestically in China and to international markets.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Aimin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aimin Pharmaceutical.

Explore the full profile